Xingping Ge

Yantaishan Hospital No. 167 Jichang Road, Zhifu District 264025 Yantai Shandong P. R. China +86 13589807433
Xiangyang, 135898, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

The Addition of Peripheral Blood Inflammatory Indexes to Nomogram Improves the Predictive Accuracy of Survival in Limited-Stage Small Cell Lung Cancer Patients.

The Addition of Peripheral Blood Inflammatory Indexes to Nomogram Improves the Predictive Accuracy of Survival in Limited-Stage Small Cell Lung Cancer Patients.

Journal: Frontiers in oncology

Published: May 21, 2021

Prognostic role of targeted therapy in patients with multiple-site metastases from non-small- cell lung cancer.

Prognostic role of targeted therapy in patients with multiple-site metastases from non-small- cell lung cancer.

Journal: Future oncology (London, England)

Published: July 21, 2020

Efficacy of neoadjuvant chemotherapy combined with intraperitoneal hyperthermic chemotherapy in advanced ovarian cancer.

Efficacy of neoadjuvant chemotherapy combined with intraperitoneal hyperthermic chemotherapy in advanced ovarian cancer.

Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology

Published: June 12, 2020

A multicentre survey of pain management in cancer patients and physicians attending radiotherapy clinics in Shandong Province, China.

A multicentre survey of pain management in cancer patients and physicians attending radiotherapy clinics in Shandong Province, China.

Journal: The Journal of international medical research

Published: October 08, 2019

Radiomics signature extracted from diffusion-weighted magnetic resonance imaging predicts outcomes in osteosarcoma.

Radiomics signature extracted from diffusion-weighted magnetic resonance imaging predicts outcomes in osteosarcoma.

Journal: Journal of bone oncology

Published: August 14, 2019

Apatinib inhibits macrophage-mediated epithelial-mesenchymal transition in lung cancer.

Apatinib inhibits macrophage-mediated epithelial-mesenchymal transition in lung cancer.

Journal: RSC advances

Published: February 08, 2018

MicroRNA-454 inhibits non‑small cell lung cancer cells growth and metastasis via targeting signal transducer and activator of transcription-3.

MicroRNA-454 inhibits non‑small cell lung cancer cells growth and metastasis via targeting signal transducer and activator of transcription-3.

Journal: Molecular medicine reports

Published: June 08, 2016

[Retracted] MicroRNA‑454 inhibits non‑small cell lung cancer cells growth and metastasis via targeting signal transducer and activator of transcription‑3.

[Retracted] MicroRNA‑454 inhibits non‑small cell lung cancer cells growth and metastasis via targeting signal transducer and activator of transcription‑3.

Journal: Molecular medicine reports

Published: June 08, 2016

Drug resistance analysis of gefitinib-targeted therapy in non-small cell lung cancer.

Drug resistance analysis of gefitinib-targeted therapy in non-small cell lung cancer.

Journal: Oncology letters

Published: April 21, 2016

Showing 1-9 of 9

Last Updated: 09/26/2026